Chong Kun Dang Pharmaceutical (185750) — Cash Flow-to-Debt Ratio
Chong Kun Dang Pharmaceutical (185750) has a Cash Flow-to-Debt Ratio of 0.02x as of March 2026, meaning its operating cash flow of ₩12.32 Billion could theoretically repay 0% of its total liabilities (₩803.02 Billion) in one year. Explore Chong Kun Dang Pharmaceutical (185750) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Chong Kun Dang Pharmaceutical Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Chong Kun Dang Pharmaceutical across 10 annual periods. Also explore balance sheet size of Chong Kun Dang Pharmaceutical for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Chong Kun Dang Pharmaceutical (2016–2025)
Year-by-year debt coverage analysis for Chong Kun Dang Pharmaceutical. For market capitalisation and broader financial context, see 185750 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | ₩67.36 Billion | ₩793.94 Billion | ▼ -25.8% |
| 2024 | 0.11x | ₩64.29 Billion | ₩562.39 Billion | ▼ -78.9% |
| 2023 | 0.54x | ₩318.16 Billion | ₩586.79 Billion | ▲ +303.1% |
| 2022 | 0.13x | ₩67.73 Billion | ₩503.59 Billion | ▲ +401.3% |
| 2021 | 0.03x | ₩12.90 Billion | ₩480.89 Billion | ▼ -89.8% |
| 2020 | 0.26x | ₩104.32 Billion | ₩394.74 Billion | ▲ +11.6% |
| 2019 | 0.24x | ₩77.29 Billion | ₩326.40 Billion | ▲ +55.9% |
| 2018 | 0.15x | ₩42.63 Billion | ₩280.60 Billion | ▼ -49.1% |
| 2017 | 0.30x | ₩81.67 Billion | ₩273.91 Billion | ▲ +48.3% |
| 2016 | 0.20x | ₩57.79 Billion | ₩287.45 Billion | — |